Kenichi Nishimura

985 total citations
66 papers, 546 citations indexed

About

Kenichi Nishimura is a scholar working on Molecular Biology, Hematology and Surgery. According to data from OpenAlex, Kenichi Nishimura has authored 66 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Hematology and 14 papers in Surgery. Recurrent topics in Kenichi Nishimura's work include Autoimmune and Inflammatory Disorders Research (16 papers), Adolescent and Pediatric Healthcare (8 papers) and Inflammasome and immune disorders (7 papers). Kenichi Nishimura is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (16 papers), Adolescent and Pediatric Healthcare (8 papers) and Inflammasome and immune disorders (7 papers). Kenichi Nishimura collaborates with scholars based in Japan, Iran and United States. Kenichi Nishimura's co-authors include Nobuya Inagaki, Hiroaki Iijima, Nobuhiro Nakanishi, Nobuko Maruyama, Kazuoki Kondo, Masaaki Mori, Yumi Watanabe, Takashi Kadowaki, M. Wafik Gouda and Yoshihiro Nozaki and has published in prestigious journals such as Scientific Reports, Journal of neurosurgery and Annals of the Rheumatic Diseases.

In The Last Decade

Kenichi Nishimura

55 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenichi Nishimura Japan 14 131 111 95 93 66 66 546
María Teresa Rivera Belgium 12 91 0.7× 50 0.5× 131 1.4× 41 0.4× 32 0.5× 17 862
Nabil Hassan Egypt 13 79 0.6× 65 0.6× 106 1.1× 33 0.4× 47 0.7× 40 613
Martin Kankam United States 15 213 1.6× 35 0.3× 125 1.3× 211 2.3× 148 2.2× 34 824
James E. Rogers United States 11 127 1.0× 25 0.2× 124 1.3× 65 0.7× 62 0.9× 18 664
Xiaoting Lu China 13 105 0.8× 40 0.4× 35 0.4× 30 0.3× 15 0.2× 34 698
Thomas G. Bell United States 15 143 1.1× 81 0.7× 41 0.4× 52 0.6× 132 2.0× 45 739
Yehezkel Naveh Israel 18 97 0.7× 43 0.4× 178 1.9× 35 0.4× 23 0.3× 68 804
Ayşenur Atay Türkiye 10 114 0.9× 25 0.2× 49 0.5× 44 0.5× 15 0.2× 17 566
B. S. Das India 19 112 0.9× 35 0.3× 223 2.3× 31 0.3× 13 0.2× 58 1.1k
J L Maddocks United Kingdom 13 129 1.0× 60 0.5× 46 0.5× 20 0.2× 34 0.5× 34 630

Countries citing papers authored by Kenichi Nishimura

Since Specialization
Citations

This map shows the geographic impact of Kenichi Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenichi Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenichi Nishimura more than expected).

Fields of papers citing papers by Kenichi Nishimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenichi Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenichi Nishimura. The network helps show where Kenichi Nishimura may publish in the future.

Co-authorship network of co-authors of Kenichi Nishimura

This figure shows the co-authorship network connecting the top 25 collaborators of Kenichi Nishimura. A scholar is included among the top collaborators of Kenichi Nishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenichi Nishimura. Kenichi Nishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hiejima, Eitaro, Kazushi Izawa, Kenichi Nishimura, et al.. (2025). The first nationwide epidemiological survey of chronic recurrent multifocal osteomyelitis in Japan. Modern Rheumatology. 35(6). 1047–1056.
2.
Nozawa, Tomo, et al.. (2025). Intolerance of oral methotrexate in juvenile idiopathic arthritis. Pediatrics International. 67(1). e70112–e70112.
5.
Nozawa, Tomo, et al.. (2023). Purple eyelid sign in multisystem inflammatory syndrome in children. Pediatrics International. 65(1). e15510–e15510. 1 indexed citations
6.
Nozawa, Tomo, Kenichi Nishimura, Ryoki Hara, et al.. (2023). Characteristics of persistent arthritis with refractory Kawasaki disease: a single-center retrospective study. Scientific Reports. 13(1). 9890–9890.
7.
Kurita, Daisuke, Takashi Ohya, Ayako Murase, et al.. (2023). Severe RAS-Associated Lymphoproliferative Disease Case with Increasing αβ Double-Negative T Cells with Atypical Features. Journal of Clinical Immunology. 43(8). 1992–1996. 3 indexed citations
8.
Shimizu, Masaki, Kenichi Nishimura, Naomi Iwata, et al.. (2023). Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan. International Journal of Rheumatic Diseases. 26(5). 938–945. 2 indexed citations
9.
Yamasaki, Yuichi, Norimoto Kobayashi, Kazuko Yamazaki, et al.. (2021). Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: multicentre study. Lara D. Veeken. 60(10). 4821–4831. 20 indexed citations
10.
Yamazaki, Kazuko, Akiko Ohta, Yuichi Yamasaki, et al.. (2020). External validation of the EULAR/ACR idiopathic inflammatory myopathies classification criteria with a Japanese paediatric cohort. Lara D. Veeken. 60(2). 802–808. 3 indexed citations
11.
Ohnishi, Hidenori, Norio Kawamoto, Tomohiro Hori, et al.. (2020). Immunophenotyping of A20 haploinsufficiency by multicolor flow cytometry. Clinical Immunology. 216. 108441–108441. 8 indexed citations
12.
Takeuchi, Ichiro, Toshinao Kawai, Ohsuke Migita, et al.. (2020). X-linked inhibitor of apoptosis protein deficiency complicated with Crohn's disease-like enterocolitis and Takayasu arteritis: A case report. Clinical Immunology. 217. 108495–108495. 9 indexed citations
13.
Shimizu, Masaki, Mao Mizuta, Nami Okamoto, et al.. (2020). Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Pediatric Rheumatology. 18(1). 2–2. 32 indexed citations
14.
Yashiro, Masato, Nami Okamoto, Hiroaki Umebayashi, et al.. (2019). Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ). Pediatric Rheumatology. 17(1). 15–15. 23 indexed citations
15.
Hara, Ryoki, Kenichi Nishimura, Tomo Nozawa, et al.. (2015). A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in Japan.. PubMed. 25(6). 858–64. 5 indexed citations
17.
Shirahase, Hiroaki, et al.. (1999). AS-924, a Novel Bifunctional Prodrug of Ceftioxime.. The Journal of Antibiotics. 52(5). 491–500. 5 indexed citations
18.
Takagi, Mitsuhiro, Kenichi Nishimura, N. Oguri, et al.. (1998). Measurement of early pregnancy factor activity for monitoring the viability of the equine embryo. Theriogenology. 50(2). 255–262. 10 indexed citations
19.
ANEGAWA, Shigetaka, Takashi Hayashi, Shinken Kuramoto, et al.. (1989). Sparganosis of the brain. Journal of neurosurgery. 71(2). 287–289. 25 indexed citations
20.
Nishimura, Kenichi. (1966). Investigations on the rat lungworm, Angiostrongylus cantonensis, in the Ryukyu Islands.. Kiseichūgaku zasshi. 15(3). 232–238.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026